摘要
肝门部胆管癌是一种来源于左右肝管、肝总管及其汇合部位的恶性肿瘤。Ⅲ型和Ⅳ型肝门部胆管癌是按Bismuth-Corlette分型中发生在胆囊管开口以上且向肝内侵犯至左右一级或二级胆管分支的胆管癌。其早期临床症状不明显,多数患者在就诊时已处晚期,同时解剖位置特殊,手术难度大,R0切除率低。因此,大部分患者只能行姑息性减黄引流治疗,为进一步加深对Ⅲ型和Ⅳ型肝门部胆管癌姑息性减黄引流治疗的了解,本文就近年来相关的研究进展做一综述。
Hilar cholangiocarcinoma is a malignant disease which initiated in the main left or right hepatic ducts, ductus hepaticus communis or their confluence. Type Ⅲand Ⅳhilar cholangiocarcinoma according to Bismuth-Corlette classification originate from the superior region of the junction of ductus cysticus and common bile duct, with left/right primary branch invasion or secondary branch invasion, respectively. For lack of tipical symptoms,most patients are diagnosed at advanced stage. Meanwhile,because of special anatomical structures, difficulty in operation and low rate for RO resection, most patients can only undergo palliative treatment of draining and reducing jaundice.In order to deepen the understanding of the palliative treatment of draining and reducing jaundice for Type Ⅲand Ⅳhilar cholangiocarcinoma,this review summarized the related research progress.
出处
《兰州大学学报(医学版)》
CAS
2016年第5期62-67,共6页
Journal of Lanzhou University(Medical Sciences)
基金
甘肃省自然科学基金项目(145RJA113)
"西部之光"人才培养引进计划项目(科发人涵字(2015)90号)
甘肃省陇原青年创新人才扶持计划金项目(甘组通字[2015]90号)
甘肃省中医药管理局科研项目(GZK-2015-69)
关键词
肝门部胆管癌
内镜
引流
经皮肝穿刺胆管引流术
支架
hilar cholangiocarcinoma
endoscopy
drainage
percutaneous transhepatic cholangial drainage
stents